Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CLK2 encodes a member of the CLK family of dual specificity protein kinases. Additionally we are shipping CLK2 Proteins (5) and CLK2 Kits (3) and many more products for this protein.
Showing 10 out of 94 products:
Human Polyclonal CLK2 Primary Antibody for EIA, WB - ABIN951572
Nam, Seo, Park, An, Kim, Yang, Kim, Jeong, Jin: Phosphorylation of CLK2 at serine 34 and threonine 127 by AKT controls cell survival after ionizing radiation. in The Journal of biological chemistry 2010
Show all 4 references for ABIN951572
Human Polyclonal CLK2 Primary Antibody for EIA, WB - ABIN359676
Winfield, Tayebi, Martin, Ginns, Sidransky: Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease. in Genome research 1997
Show all 3 references for ABIN359676
Human Polyclonal CLK2 Primary Antibody for WB - ABIN391766
Yoshida, Kim, Carver, Su, Weremowicz, Mulvey, Yamamoto, Brennan, Mei, Long, Yao, Polyak: CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer. in Cancer research 2015
Show all 2 references for ABIN391766
Clk1 (show CDK11B Antibodies), Clk2 and Clk4 (show CLK4 Antibodies) prevent chromatin breakage by regulating the Aurora B (show AURKB Antibodies)-dependent abscission checkpoint.
Loss of CLK2 in luminal breast cancer cells leads to the upregulation of epithelial-to-mesenchymal transition (EMT (show ITK Antibodies))-related genes and a switch to mesenchymal splice variants of several genes.
LAMMER/Cdc2 (show CDK1 Antibodies)-like kinase, represented by Doa and its mammalian homolog CLK2, is a critical and conserved component in the regulatory program of the mitosis-to-meiosis switch
CLK1 (show CDK11B Antibodies) Increases While CLK2 Decreases HIV-1 Gene Expression.
AKT (show AKT1 Antibodies) activation controls cell survival to ionizing radiation by phosphorylating CLK2, revealing an important regulatory mechanism required for promoting cell survival.
Cdc2 (show CDK1 Antibodies)-like kinases and DNA topoisomerase I (show TOP1 Antibodies) regulate alternative splicing of tissue factor (show F3 Antibodies) in human endothelial cells.
Liver-specific Clk2 knockout mice fed a high-fat diet exhibit increased fasting levels of blood ketone bodies, reduced respiratory exchange ratio, and increased gene expression of fatty acid oxidation and ketogenic pathways.
Cdc2 (show CDK1 Antibodies)-like kinase 2 (Clk2) directly phosphorylates the SR domain on PGC-1alpha (show PPARGC1A Antibodies), resulting in repression of gluconeogenic gene expression and hepatic glucose output.
This gene encodes a member of the CLK family of dual specificity protein kinases. CLK family members have been shown to interact with, and phosphorylate, serine- and arginine-rich (SR) proteins of the spliceosomal complex, which is a part of the regulatory mechanism that enables the SR proteins to control RNA splicing. Note that this gene is distinct from TELO2 gene (GeneID:9894), which shares CLK2 and hCLK2 symbol aliases in common with this gene, but encodes a protein that is involved in telomere length regulation.
CDC-like kinase 2
, dual specificity protein kinase CLK2
, CLK kinase
, Clk2-Scamp3 protein